| Kalambur Visvanathan Panchapakesan, MD | |
|
2400 Mount Zion Pkwy, Kaiser Permanente Southwood Comprehensive Medical Cente, Jonesboro, GA 30236-2500 | |
| (770) 603-3649 | |
| Not Available |
| Full Name | Kalambur Visvanathan Panchapakesan |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 47 Years |
| Location | 2400 Mount Zion Pkwy, Jonesboro, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750325866 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 042912 (California) | Secondary |
| 207P00000X | Emergency Medicine | 042912 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Southeast Permanente Medical Group | 6204829013 | 576 |
News Archive
Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography.
Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
The Environmental Protection Agency has now approved the use of special mosquitoes that have been infected with bacteria called Wolbachia for eradication of mosquitoes in 20 states and District of Columbia. This approach is known as the use of "biopesticide". Now mosquitoes that spread viral illnesses like Dengue, Chikungunya, Zika etc. would be controlled effectively.
Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.
EndoStim, Inc., a medical device company developing minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, today announced it has raised $6 million in Series B equity financing. Santé Ventures, a life science venture capital firm, led the round and was joined by the Prolog Ventures, Vectis Healthcare & Life Sciences Fund II and returning angel investors.
› Verified 1 days ago
| Entity Name | The Southeast Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245266956 PECOS PAC ID: 6204829013 Enrollment ID: O20040407000370 |
News Archive
Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography.
Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
The Environmental Protection Agency has now approved the use of special mosquitoes that have been infected with bacteria called Wolbachia for eradication of mosquitoes in 20 states and District of Columbia. This approach is known as the use of "biopesticide". Now mosquitoes that spread viral illnesses like Dengue, Chikungunya, Zika etc. would be controlled effectively.
Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.
EndoStim, Inc., a medical device company developing minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, today announced it has raised $6 million in Series B equity financing. Santé Ventures, a life science venture capital firm, led the round and was joined by the Prolog Ventures, Vectis Healthcare & Life Sciences Fund II and returning angel investors.
› Verified 1 days ago
| Entity Name | Central Georgia Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598126641 PECOS PAC ID: 5991004608 Enrollment ID: O20160502001926 |
News Archive
Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography.
Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
The Environmental Protection Agency has now approved the use of special mosquitoes that have been infected with bacteria called Wolbachia for eradication of mosquitoes in 20 states and District of Columbia. This approach is known as the use of "biopesticide". Now mosquitoes that spread viral illnesses like Dengue, Chikungunya, Zika etc. would be controlled effectively.
Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.
EndoStim, Inc., a medical device company developing minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, today announced it has raised $6 million in Series B equity financing. Santé Ventures, a life science venture capital firm, led the round and was joined by the Prolog Ventures, Vectis Healthcare & Life Sciences Fund II and returning angel investors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kalambur Visvanathan Panchapakesan, MD 3495 Piedmont Rd Ne, Nine Piedmont Center, Atlanta, GA 30305-1717 Ph: (404) 504-5678 | Kalambur Visvanathan Panchapakesan, MD 2400 Mount Zion Pkwy, Kaiser Permanente Southwood Comprehensive Medical Cente, Jonesboro, GA 30236-2500 Ph: (770) 603-3649 |
News Archive
Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography.
Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
The Environmental Protection Agency has now approved the use of special mosquitoes that have been infected with bacteria called Wolbachia for eradication of mosquitoes in 20 states and District of Columbia. This approach is known as the use of "biopesticide". Now mosquitoes that spread viral illnesses like Dengue, Chikungunya, Zika etc. would be controlled effectively.
Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.
EndoStim, Inc., a medical device company developing minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, today announced it has raised $6 million in Series B equity financing. Santé Ventures, a life science venture capital firm, led the round and was joined by the Prolog Ventures, Vectis Healthcare & Life Sciences Fund II and returning angel investors.
› Verified 1 days ago
Lynn Kevin Flowers, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2400 Mt. Zion Parkway, Kaiser Permanente Southwood Medical Center, Jonesboro, GA 30236 Phone: 770-603-3668 Fax: 912-691-1953 | |
Joseph Paul Brissette, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Mount Zion Pkwy, Kaiser Permanente Southwood Medical Center, Jonesboro, GA 30236 Phone: 770-603-3649 Fax: 770-994-4747 | |
Dr. Stanley Llewellyn Allen Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Mt. Zion Parkway Kaiser Permanente, Southwood Comprehensive Medical Center, Jonesboro, GA 30236 Phone: 770-365-0966 | |
Uchenna E Aguwa, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Mt. Zion Parkway, Kaiser Permanente Southwood Medical Center, Jonesboro, GA 30236 Phone: 770-603-3668 Fax: 740-374-1693 | |
Shakira N. Thomas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Mount Zion Pkwy, Kaiser Permanente Southwood Medical Center, Jonesboro, GA 30236 Phone: 205-616-5289 | |
Dr. Michele Renee Hayek, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Mt. Zion Parkway, Kaiser Permanente, Jonesboro, GA 30236 Phone: 770-603-3649 | |
Dr. Angie Harshaw Harris, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Mount Zion Pkwy, Kaiser Permanente Southwood Comprehensive Medical Cente, Jonesboro, GA 30236 Phone: 770-603-3668 |